Cargando…

Cariprazine Exhibits Anxiolytic and Dopamine D(3) Receptor-Dependent Antidepressant Effects in the Chronic Stress Model

BACKGROUND: Cariprazine, a D(3)-preferring dopamine D(2)/D(3) receptor partial agonist, is a new antipsychotic drug recently approved in the United States for the treatment of schizophrenia and bipolar mania. We recently demonstrated that cariprazine also has significant antianhedonic-like effects i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duric, Vanja, Banasr, Mounira, Franklin, Tina, Lepack, Ashley, Adham, Nika, Kiss, Béla, Gyertyán, István, Duman, Ronald S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Regular Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632312/ https://www.ncbi.nlm.nih.gov/pubmed/28531264 http://dx.doi.org/10.1093/ijnp/pyx038

Ejemplares similares

Cariprazine exerts antimanic properties and interferes with dopamine D(2) receptor β-arrestin interactions
por: Gao, Yonglin, et al.
Publicado: (2015)

Effects of cariprazine on extracellular levels of glutamate, GABA, dopamine, noradrenaline and serotonin in the medial prefrontal cortex in the rat phencyclidine model of schizophrenia studied by microdialysis and simultaneous recordings of locomotor activity
por: Kehr, Jan, et al.
Publicado: (2018)

The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task
por: Barnes, Samuel A., et al.
Publicado: (2018)

Correction to: The Effects of Cariprazine and Aripiprazole on PCP-Induced Deficits on Attention Assessed in the 5-Choice Serial Reaction Time Task
por: Barnes, Samuel A., et al.
Publicado: (2018)

The novel atypical antipsychotic cariprazine demonstrates dopamine D(2) receptor‐dependent partial agonist actions on rat mesencephalic dopamine neuronal activity
por: Delcourte, Sarah, et al.
Publicado: (2018)

Characterization of GABAergic Marker Expression in the Chronic Unpredictable Stress Model of Depression
por: Banasr, Mounira, et al.
Publicado: (2017)

Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine
por: Kiss, Béla, et al.
Publicado: (2019)

BDNF Release Is Required for the Behavioral Actions of Ketamine
por: Lepack, Ashley E., et al.
Publicado: (2014)

Preferential Effects of Cariprazine on Counteracting the Disruption of Social Interaction and Decrease in Extracellular Dopamine Levels Induced by the Dopamine D(3) Receptor Agonist, PD-128907 in Rats: Implications for the Treatment of Negative and Depressive Symptoms of Psychiatric Disorders
por: Kehr, Jan, et al.
Publicado: (2022)

The novel antipsychotic cariprazine stabilizes gamma oscillations in rat hippocampal slices
por: Meier, Maria A., et al.
Publicado: (2020)

Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
por: Román, Viktor, et al.
Publicado: (2021)

Binding kinetics of cariprazine and aripiprazole at the dopamine D(3) receptor
por: Frank, Annika, et al.
Publicado: (2018)

Preferential binding to dopamine D(3) over D(2) receptors by cariprazine in patients with schizophrenia using PET with the D(3)/D(2) receptor ligand [(11)C]-(+)-PHNO
por: Girgis, Ragy R., et al.
Publicado: (2016)

Search for novel antipsychotic drugs: dopamine forever?
por: Gyertyán, István
Publicado: (2009)

Negative Regulator of MAP Kinase is Increased in Depression and Is Necessary and Sufficient for Expression of Depressive Behavior
por: Duric, Vanja, et al.
Publicado: (2010)

Atranorin, a Secondary Metabolite of Lichens, Exhibited Anxiolytic/Antidepressant Activity in Wistar Rats
por: Urbanska, Nicol, et al.
Publicado: (2022)

Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation
por: Ram, Daya, et al.
Publicado: (2015)

The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
por: Radosavljevic, Milica, et al.
Publicado: (2023)

Decreased SGK1 Expression and Function Contributes to Behavioral Deficits Induced by Traumatic Stress
por: Licznerski, Pawel, et al.
Publicado: (2015)

Transiently increased glutamate cycling in rat PFC is associated with rapid onset of antidepressant-like effects
por: Chowdhury, Golam M. I., et al.
Publicado: (2016)

Cariprazine pharmacokinetics
Publicado: (2022)

ANXIETY AND DEPRESSIVE NEUROSIS - THEIR RESPONSE TO ANXIOLYTIC AND ANTIDEPRESSANT TREATMENT
por: Singh, Gurmeet, et al.
Publicado: (1987)

Antidepressant and Anxiolytic Potentials of the Chewing Stick, Salvadora persica
por: Vasudevan, Rajalakshimi, et al.
Publicado: (2023)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Evaluation of Antidepressant and Anxiolytic Activity of Phosphodiesterase 3 Inhibitor - Cilostazol
por: Patel, Dipesh S., et al.
Publicado: (2012)

Examining the short-term anxiolytic and antidepressant effect of Floatation-REST
por: Feinstein, Justin S., et al.
Publicado: (2018)

Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond
por: Zorumski, Charles F., et al.
Publicado: (2019)

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial
por: Martin, Erin L., et al.
Publicado: (2021)

Anxiolytic and antidepressant potential of extracts of Duchesnea Indica in animal models
por: Mohibullah,, et al.
Publicado: (2022)

Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
por: Durgam, Suresh, et al.
Publicado: (2016)

Antidepressive and anxiolytic effects of ostruthin, a TREK-1 channel activator
por: Joseph, Ancy, et al.
Publicado: (2018)

Antidepressant, Anxiolytic and Neuroprotective Activities of Two Zinc Compounds in Diabetic Rats
por: Cavalcanti, Christiane Leite, et al.
Publicado: (2020)

Exogenous Carbon Monoxide Produces Rapid Antidepressant- and Anxiolytic-Like Effects
por: Luo, Yixiao, et al.
Publicado: (2021)

Anxiolytic and Antidepressant Use and Burnout: Optimism as a Mediator in Spanish Nurses
por: Martos Martínez, África, et al.
Publicado: (2021)

Anxiolytic and antidepressants’ effect of Crataegus pinnatifida (Shan Zha): biochemical mechanisms
por: Nitzan, Keren, et al.
Publicado: (2022)

Anxiolytic, antidepressant and antioxidant activity of the methanol extract of Canarium resiniferum leaves
por: Shah, Md Shahin, et al.
Publicado: (2022)

Antidepressant and Anxiolytic Effects of Fermented Huauzontle, a Prehispanic Mexican Pseudocereal
por: Santiago-López, Lourdes, et al.
Publicado: (2022)

Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia
por: Tiger, Mikael, et al.
Publicado: (2023)

Anxiolytic and Antidepressant Potential of Methanolic Extract of Neurada procumbens Linn. in Mice
por: Khalid, Ahmed Awais, et al.
Publicado: (2023)

mGluR2/3 blockade produces rapid and long-lasting reversal of anhedonia caused by chronic stress exposure
por: Dwyer, Jason M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_m789lsno6jn4ruq688mujttdha